Together for an innovative and world-leading Swiss metaverse ecosystem. This is the motto under which 47 partners from business, science and administration have founded the Swiss Metaverse Association. Kellerhals Carrard is one of the founding members
CIMO Compagnie industrielle de Monthey entered into an agreement with the Swiss Confederation, under which the latter may use the thermic power plant Thermatel in Monthey as strategic backup source in case of electricity shortfalls.
The Board of Directors of LUKS Group has elected Jacqueline Rohrbach as the new Head of Human Resources. She will take up her post on 1 October 2023. Rohrbach completed a Master’s degree in Business Administration
The Initiative & Finance Group has acquired the share capital of CSD Engineers Group. This new partnership will enable CSD to achieve its growth ambitions as a leading engineering company in Switzerland and abroad. With
Niederer Kraft Frey has advised Bearmind as Swiss counsel on its seed financing round led by HH Equity Partners II. The EPFL spinoff has secured CHF 1.3 million in the seed round that also included participation
Fundamenta Group Holding has acquired 100% of the shares of Belvédère Asset Management. In return, the previous shareholders of Belvédère Asset Management will acquire a stake in Fundamenta Group. Following the closing
Niederer Kraft Frey advised Clariant in connection with its new CHF 450 million sustainability-linked syndicated revolving credit facility agreement with Skandinaviska Enskilda Banken, Citibank, BNP Paribas, Commerzbank, Credit Suisse, Deutsche Bank and UBS acting as bookrunners
The Swiss startup AICA has closed a CHF 1.2 million financing round to give robots a sense of touch and enable autonomous learning. Niederer Kraft Frey advised AICA as Swiss counsel on its seed financing round
Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system disorders, successfully closed an oversubscribed Series B financing round, raising CHF 103 mio (approx. USD 112 mio). The round was co-led by the European healthcare focused
Santhera Pharmaceuticals Holding announced a private placement of shares and an amendment of its existing financing with funds managed by Highbridge Capital Management to provide up to CHF 22.2 million in aggregate, subject to certain milestones
